Compounds

ALA5272566

Name:
(4-((4-(Pyrrolidin-1-yl)piperidin-1-yl)sulfonyl)benzoyl)glycine

Mol. Formula:
C18H25N3O5S

M.W.:
395.48

Type:
---

AlogP:
0.75

Polar Surface Area:
107.02

HBA:
5

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.74

DETAILS

ALA5271929

Name:
(2-Fluoro-4((4-phenylpiperidin-1-yl)sulfonyl)benzoyl)glycine

Mol. Formula:
C20H21FN2O5S

M.W.:
420.46

Type:
---

AlogP:
2.21

Polar Surface Area:
103.78

HBA:
4

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.75

DETAILS

ALA5270943

Name:
(5-((4-Phenylpiperidin-1-yl)sulfonyl)picolinoyl)glycine

Mol. Formula:
C19H21N3O5S

M.W.:
403.46

Type:
---

AlogP:
1.46

Polar Surface Area:
116.67

HBA:
5

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.75

DETAILS

ALA5270844

Name:
(4-((3-Methyl-4-phenylpiperidin-1-yl)sulfonyl)benzoyl)glycine

Mol. Formula:
C21H24N2O5S

M.W.:
416.50

Type:
---

AlogP:
2.32

Polar Surface Area:
103.78

HBA:
4

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.75

DETAILS

ALA5270273

Name:
(4-((4-Phenyl-3,6-dihydropyridin-1(2H)-yl)sulfonyl)benzoyl)-glycine

Mol. Formula:
C20H20N2O5S

M.W.:
400.46

Type:
---

AlogP:
1.98

Polar Surface Area:
103.78

HBA:
4

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.77

DETAILS

ALA5269641

Name:
(4-((3-Phenylazetidin-1-yl)sulfonyl)benzoyl)glycine

Mol. Formula:
C18H18N2O5S

M.W.:
374.42

Type:
---

AlogP:
1.29

Polar Surface Area:
103.78

HBA:
4

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.79

DETAILS

ALA5269269

Name:
(4-((4-(3-Fluorophenyl)piperidin-1-yl)sulfonyl)benzoyl)glycine

Mol. Formula:
C20H21FN2O5S

M.W.:
420.46

Type:
---

AlogP:
2.21

Polar Surface Area:
103.78

HBA:
4

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.75

DETAILS

ALA5268432

Name:
(4-((9-Methyl-3,9-diazaspiro[5.5]undecan-3-yl)sulfonyl)benzoyl)glycine

Mol. Formula:
C19H27N3O5S

M.W.:
409.51

Type:
---

AlogP:
1.00

Polar Surface Area:
107.02

HBA:
5

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
5

Passes Ro3:
N

QED Weighted:
0.75

DETAILS

ALA5268349

Name:
(3-((4-Phenylpiperidin-1-yl)sulfonyl)benzoyl)glycine

Mol. Formula:
C20H22N2O5S

M.W.:
402.47

Type:
---

AlogP:
2.07

Polar Surface Area:
103.78

HBA:
4

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.77

DETAILS

ALA5268053

Name:
(4-((4-(4-Methylpiperazin-1-yl)piperidin-1-yl)sulfonyl)benzoyl)glycine

Mol. Formula:
C19H28N4O5S

M.W.:
424.52

Type:
---

AlogP:
-0.10

Polar Surface Area:
110.26

HBA:
6

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.66

DETAILS

ALA5282674

Name:
(4-((4-(3-Chlorophenyl)piperidin-1-yl)sulfonyl)benzoyl)glycine

Mol. Formula:
C20H21ClN2O5S

M.W.:
436.92

Type:
---

AlogP:
2.72

Polar Surface Area:
103.78

HBA:
4

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.72

DETAILS

ALA5282333

Name:
(4-((4-Phenylpiperazin-1-yl)sulfonyl)benzoyl)glycine

Mol. Formula:
C19H21N3O5S

M.W.:
403.46

Type:
---

AlogP:
1.01

Polar Surface Area:
107.02

HBA:
5

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.75

DETAILS

ALA5282322

Name:
2-(4-(4-(3,4-difluorophenyl)piperidin-1-ylsulfonyl)benzamido)acetic acid

Mol. Formula:
C20H20F2N2O5S

M.W.:
438.45

Type:
---

AlogP:
2.35

Polar Surface Area:
103.78

HBA:
4

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.72

DETAILS

ALA5282232

Name:
(5-((4-phenylpiperidin-1-yl)sulfonyl)furan-2-carbonyl)glycine

Mol. Formula:
C18H20N2O6S

M.W.:
392.43

Type:
---

AlogP:
1.66

Polar Surface Area:
116.92

HBA:
5

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.77

DETAILS

ALA5282155

Name:
(4-((4-Cyclopentylpiperidin-1-yl)sulfonyl)benzoyl)glycine

Mol. Formula:
C19H26N2O5S

M.W.:
394.49

Type:
---

AlogP:
2.09

Polar Surface Area:
103.78

HBA:
4

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.77

DETAILS

ALA5281654

Name:
(4-((4-(4-Chlorophenyl)piperidin-1-yl)sulfonyl)benzoyl)glycine

Mol. Formula:
C20H21ClN2O5S

M.W.:
436.92

Type:
---

AlogP:
2.72

Polar Surface Area:
103.78

HBA:
4

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.72

DETAILS

ALA5280865

Name:
(3-Methyl-5-((4-phenylpiperidin-1-yl)sulfonyl)thiophene-2-carbonyl)glycine

Mol. Formula:
C19H22N2O5S2

M.W.:
422.53

Type:
---

AlogP:
2.44

Polar Surface Area:
103.78

HBA:
5

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.74

DETAILS

ALA5279202

Name:
(5-((4-Phenylpiperidin-1-yl)sulfonyl)thiophene-3-carbonyl)glycine

Mol. Formula:
C18H20N2O5S2

M.W.:
408.50

Type:
---

AlogP:
2.13

Polar Surface Area:
103.78

HBA:
5

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.76

DETAILS

ALA5278336

Name:
(5-((4-(4-Chlorophenyl)piperidin-1-yl)sulfonyl)picolinoyl)glycine

Mol. Formula:
C19H20ClN3O5S

M.W.:
437.91

Type:
---

AlogP:
2.12

Polar Surface Area:
116.67

HBA:
5

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.71

DETAILS

ALA5276984

Name:
(1-Methyl-4-((4-phenylpiperidin-1-yl)sulfonyl)-1H-pyrrole-2-carbonyl)glycinShow More⌵

Mol. Formula:
C19H23N3O5S

M.W.:
405.48

Type:
---

AlogP:
1.41

Polar Surface Area:
108.71

HBA:
5

HBD:
2

#RO5 Violations:
---

#Rotatable Bonds:
6

Passes Ro3:
N

QED Weighted:
0.76

DETAILS